A Study to Assess the Use of The Sentinel Device During Atrial Fibrillation Ablation

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Atrial Fibrillation
Interventions
DEVICE

Magnetic Resonance Imaging (MRI)

Cerebral MRI will be performed without gadolinium contrast using a 3 Tesla scanner prior to and 1 to 7 days after catheter ablation

OTHER

Laboratory Testing

Laboratory blood testing to include high sensitivity CRP (hs-CRP), interleukin-6 (IL-6), NT-proBNP and high sensitivity troponin prior to and post-ablation

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Mayo Clinic

OTHER

NCT04683692 - A Study to Assess the Use of The Sentinel Device During Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter